LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.29 | 84.90 | 574 | 7934 | 0.0723 | 0.3390 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.29 | 84.90 | 7505 | 7934 | 0.9459 | 0.9831 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.29 | 84.90 | 6816 | 7934 | 0.8590 | 0.9541 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 62.29 | 84.90 | 6891 | 7934 | 0.8685 | 0.9574 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.99 | 84.90 | 624 | 8212 | 0.0760 | 0.3531 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.99 | 84.90 | 7796 | 8212 | 0.9493 | 0.9843 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.99 | 84.90 | 7076 | 8212 | 0.8616 | 0.9554 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 63.99 | 84.90 | 7141 | 8212 | 0.8695 | 0.9581 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.70 | 84.90 | 641 | 8484 | 0.0756 | 0.3557 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.70 | 84.90 | 8076 | 8484 | 0.9519 | 0.9852 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.70 | 84.90 | 7227 | 8484 | 0.8518 | 0.9523 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 65.70 | 84.90 | 7356 | 8484 | 0.8670 | 0.9575 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.41 | 84.90 | 695 | 8766 | 0.0793 | 0.3693 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.41 | 84.90 | 8323 | 8766 | 0.9494 | 0.9846 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.41 | 84.90 | 7517 | 8766 | 0.8575 | 0.9546 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 67.41 | 84.90 | 7612 | 8766 | 0.8683 | 0.9582 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.11 | 84.90 | 723 | 8988 | 0.0804 | 0.3750 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.11 | 84.90 | 8523 | 8988 | 0.9483 | 0.9843 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.11 | 84.90 | 7637 | 8988 | 0.8497 | 0.9522 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 69.11 | 84.90 | 7791 | 8988 | 0.8668 | 0.9580 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.81 | 84.90 | 795 | 9132 | 0.0871 | 0.3930 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.81 | 84.90 | 8769 | 9132 | 0.9603 | 0.9880 | MN20160318_Q02 | F15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.81 | 84.90 | 7894 | 9132 | 0.8644 | 0.9573 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 70.81 | 84.90 | 8014 | 9132 | 0.8776 | 0.9617 | MN20160318_Q02 | N08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.01 | 72.52 | 84.90 | 868 | 9214 | 0.0942 | 0.4103 | MN20160318_Q02 | F15 |